Drug Eluting Balloons Catheters Global Market Report 2024 – Market Size, Trends, And Global Forecast 2024-2033

The Business Research Company's Drug Eluting Balloons Catheters Global Market Report 2024 – Market Size, Trends, And Global Forecast 2024-2033

LANDON, GREATER LANDON, UK, June 17, 2024 /EINPresswire.com/ -- The drug-eluting balloon catheters market, which stood at $1.23 billion in 2023, is anticipated to grow to $1.43 billion in 2024, reflecting a robust compound annual growth rate (CAGR) of 16.3%. It will grow to $2.35 billion in 2028 at a compound annual growth rate (CAGR) of 13.2%. This growth is driven by increasing respiratory disorders, patient preference for DPIs, and advancements in drug formulations, among other factors.

Rising Demand for Minimally Invasive Procedures Boosts Market Growth
The increasing preference for minimally invasive procedures is a key driver for the drug-eluting balloon catheters market. These procedures offer reduced recovery times, less pain, and lower infection risks. Drug-eluting balloons play a crucial role in these procedures by delivering anti-proliferative drugs directly to the treatment site, enhancing efficacy and reducing the likelihood of restenosis.

Explore the global drug-eluting balloon catheters market with a detailed sample report: https://www.thebusinessresearchcompany.com/sample_request?id=13429&type=smp

Key Players and Market Trends
Major companies such as Abbott Laboratories, Medtronic PLC, and Becton Dickinson are focusing on developing advanced-generation products to maintain a competitive edge. For example, Medtronic PLC launched the Prevail DCB in Europe, a next-generation drug-coated balloon catheter designed for PCI procedures, highlighting technological advancements driving market growth.

Segments:
• Product: Coronary Artery Disease Drug-Eluting Balloon Catheters, Peripheral Vascular Disease Drug-Eluting Balloon Catheters
• Drug: Paclitaxel, Sirolimus, Other Drugs
• Raw Material: Nylon, Polyurethane, Other Raw Materials
• End-User: Hospitals And Clinics, Ambulatory Surgical Centers, Catheterization Laboratories

Geographical Insights: North America Leads, Asia-Pacific Emerges as Fastest-Growing Region
North America dominated the drug-eluting balloon catheters market in 2023, driven by technological advancements and high healthcare expenditures. Meanwhile, Asia-Pacific is expected to witness the fastest growth, supported by increasing healthcare infrastructure and rising awareness about minimally invasive treatments.

Access the complete report for an in-depth analysis of the global drug-eluting balloon catheters market: https://www.thebusinessresearchcompany.com/report/drug-eluting-balloons-catheters-global-market-report

Drug Eluting Balloons Catheters Global Market Report 2024 from TBRC covers the following information:
• Market size date for the forecast period: Historical and Future
• Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
• Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Trends, opportunities, strategies and so much more.
The Drug Eluting Balloons Catheters Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on drug eluting balloons catheters market size, drug eluting balloons catheters market drivers and trends, drug eluting balloons catheters market major players, competitors' revenues, market positioning, and market growth across geographies. The drug eluting balloons catheters market report helps you gain in-depth insights on opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.

Browse Through More Similar Reports By The Business Research Company:
Narcotic Drugs Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/narcotic-drugs-global-market-report

Antiparasitic Drugs Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/antiparasitic-drugs-global-market-report

Focal Segmental Glomerulosclerosis Drugs Global Market Report 202
https://www.thebusinessresearchcompany.com/report/focal-segmental-glomerulosclerosis-drugs-global-market-report

About The Business Research Company
The Business Research Company has published over 27 industries, spanning over 8000+ markets and 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.

Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Check out our:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
X
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.